Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
VERACYTE, INC. | Director | Common Stock | 33.2K | $831K | $25.00 | Jul 16, 2024 | Direct |
GERON CORP | Director | Common Stock | 109K | $249K | $2.28 | Jan 13, 2023 | Direct |
VERACYTE, INC. | Director | Stock Option (right to buy) | 7.5K | $98.9K | $13.19 | Jun 7, 2024 | Direct |
NEKTAR THERAPEUTICS | Director | Common Stock | 23.2K | $11.4K | $0.49 | Sep 16, 2022 | Direct |
Personalis, Inc. | Director | Stock Option (right to buy) | 50K | May 17, 2024 | Direct | ||
NEKTAR THERAPEUTICS | Director | Stock Option | 20.4K | Sep 16, 2022 | Direct | ||
GERON CORP | Director | Stock Options (right to buy) | 0 | Jan 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VCYT | VERACYTE, INC. | Jul 16, 2024 | 1 | -$188K | 4 | Jul 18, 2024 | Director |
VCYT | VERACYTE, INC. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
VCYT | VERACYTE, INC. | Jun 11, 2024 | 1 | -$79.7K | 4 | Jun 13, 2024 | Director |
VCYT | VERACYTE, INC. | Jun 7, 2024 | 3 | -$26.4K | 4 | Jun 11, 2024 | Director |
PSNL | Personalis, Inc. | May 17, 2024 | 1 | $0 | 4 | May 21, 2024 | Director |
VCYT | VERACYTE, INC. | Apr 1, 2024 | 3 | -$217K | 4 | Apr 2, 2024 | Director |
VCYT | VERACYTE, INC. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
PSNL | Personalis, Inc. | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
VCYT | VERACYTE, INC. | Mar 16, 2023 | 3 | -$200K | 4 | Mar 17, 2023 | Director |
VCYT | VERACYTE, INC. | Feb 28, 2023 | 3 | -$129K | 4 | Mar 2, 2023 | Director |
GERN | GERON CORP | Jan 13, 2023 | 2 | $38.5K | 4 | Jan 17, 2023 | Director |
NKTR | NEKTAR THERAPEUTICS | Sep 16, 2022 | 2 | $0 | 4 | Sep 20, 2022 | Director |
NKTR | NEKTAR THERAPEUTICS | Sep 13, 2022 | 1 | -$76.8K | 4 | Sep 14, 2022 | Director |
VCYT | VERACYTE, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
PSNL | Personalis, Inc. | May 17, 2022 | 2 | $0 | 4 | May 19, 2022 | Director |
GERN | GERON CORP | May 10, 2022 | 1 | $0 | 4 | May 11, 2022 | Director |
GERN | GERON CORP | Apr 20, 2022 | 2 | $49.4K | 4 | Apr 21, 2022 | Director |
VCYT | VERACYTE, INC. | Dec 17, 2021 | 3 | -$164K | 4 | Dec 20, 2021 | Director |
VCYT | VERACYTE, INC. | Nov 1, 2021 | 3 | -$145M | 4 | Nov 3, 2021 | Director |
NKTR | NEKTAR THERAPEUTICS | Sep 22, 2021 | 2 | $0 | 4 | Sep 24, 2021 | Director |
VCYT | VERACYTE, INC. | Aug 2, 2021 | 2 | -$193K | 4 | Aug 4, 2021 | Director |
VCYT | VERACYTE, INC. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
PSNL | Personalis, Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |
GERN | GERON CORP | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |